1. Home
  2. TECH vs NLY Comparison

TECH vs NLY Comparison

Compare TECH & NLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • NLY
  • Stock Information
  • Founded
  • TECH 1976
  • NLY 1996
  • Country
  • TECH United States
  • NLY United States
  • Employees
  • TECH N/A
  • NLY N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • NLY Real Estate Investment Trusts
  • Sector
  • TECH Health Care
  • NLY Real Estate
  • Exchange
  • TECH Nasdaq
  • NLY Nasdaq
  • Market Cap
  • TECH 12.0B
  • NLY 10.3B
  • IPO Year
  • TECH 1989
  • NLY 1997
  • Fundamental
  • Price
  • TECH $64.92
  • NLY $21.64
  • Analyst Decision
  • TECH Buy
  • NLY Buy
  • Analyst Count
  • TECH 7
  • NLY 11
  • Target Price
  • TECH $84.29
  • NLY $21.56
  • AVG Volume (30 Days)
  • TECH 1.6M
  • NLY 7.1M
  • Earning Date
  • TECH 02-05-2025
  • NLY 01-29-2025
  • Dividend Yield
  • TECH 0.49%
  • NLY 12.02%
  • EPS Growth
  • TECH N/A
  • NLY N/A
  • EPS
  • TECH 0.98
  • NLY 1.62
  • Revenue
  • TECH $1,196,016,000.00
  • NLY $1,247,853,000.00
  • Revenue This Year
  • TECH $7.50
  • NLY N/A
  • Revenue Next Year
  • TECH $9.15
  • NLY $0.88
  • P/E Ratio
  • TECH $66.36
  • NLY $13.35
  • Revenue Growth
  • TECH 4.46
  • NLY N/A
  • 52 Week Low
  • TECH $61.16
  • NLY $17.67
  • 52 Week High
  • TECH $85.57
  • NLY $21.88
  • Technical
  • Relative Strength Index (RSI)
  • TECH 29.97
  • NLY 75.02
  • Support Level
  • TECH $63.51
  • NLY $20.45
  • Resistance Level
  • TECH $67.19
  • NLY $20.82
  • Average True Range (ATR)
  • TECH 2.76
  • NLY 0.28
  • MACD
  • TECH -0.71
  • NLY 0.09
  • Stochastic Oscillator
  • TECH 8.94
  • NLY 87.87

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About NLY Annaly Capital Management Inc.

Annaly Capital Management Inc is an American mortgage real estate investment trust. The Company owns a portfolio of real estate related investments, including mortgage pass-through certificates, collateralized mortgage obligations, credit risk transfer securities, other securities representing interests in or obligations backed by pools of mortgage loans, residential mortgage loans and mortgage servicing rights. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The Company's three investment groups are comprised of the following: Annaly Agency Group, Annaly Residential Credit Group, Annaly Mortgage Servicing Rights Group.

Share on Social Networks: